HS
MNOV icon

HighVista Strategies’s MediciNova MNOV Stock Holding History

HighVista Strategies’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,700
Closed -$63K – 125
2020
Q2 		$63K Hold
11,700
– – 0.05% 90
2020
Q1 		$44K Hold
11,700
– – 0.04% 50
2019
Q4 		$79K Buy
+11,700
New +$88K 0.06% 96

Other funds holding MNOV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JSMC
Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

HighVista Strategies's MNOV Position: Q3 2020 in Review

HighVista Strategies sold out of MediciNova (MNOV) in Q3 2020, closing a stake of 11,700 shares — an estimated $63K sold.

HighVista Strategies first reported a position in MNOV in Q4 2019 and held it in 3 quarters. The position peaked at $79K in Q4 2019. 53 funds tracked by Wall St. Rank hold MNOV as of Q3 2020.

  • HighVista Strategies reported no remaining MediciNova position as of Q3 2020 after selling out during the quarter.
  • HighVista Strategies sold 11,700 MediciNova shares in Q3 2020, an estimated $63K.
  • HighVista Strategies first reported a position in MediciNova in Q4 2019 and held it in 3 quarters.
  • HighVista Strategies's MediciNova position peaked at $79K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held MediciNova as of Q3 2020.

Based on HighVista Strategies's 13F filing for Q3 2020, filed 16 Nov 2020.